Asymmetric dimethylarginine (ADMA) modulates endothelial function--therapeutic implications

Vasc Med. 2003;8(3):149-51. doi: 10.1191/1358863x03vm501ed.
No abstract available

Publication types

  • Editorial
  • Review
  • Comment

MeSH terms

  • Animals
  • Arginine / analogs & derivatives*
  • Arginine / physiology*
  • Arginine / therapeutic use
  • Cardiovascular Diseases / drug therapy
  • Cardiovascular Diseases / metabolism*
  • Drug Therapy, Combination
  • Endothelium, Vascular / physiology*
  • Enzyme Inhibitors / metabolism*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Nitric Oxide Synthase / antagonists & inhibitors*
  • Nitric Oxide Synthase / genetics
  • Up-Regulation

Substances

  • Enzyme Inhibitors
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • N,N-dimethylarginine
  • Arginine
  • Nitric Oxide Synthase